Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Today's TLD1433 Shout Out
View:
Post by Eoganacht on Jan 14, 2025 11:57am

Today's TLD1433 Shout Out

More and more independent researchers seem to be recognizing the power of TLD1433 PDT.

https://onlinelibrary.wiley.com/doi/10.1002/anie.202423335?af=R

Advances in the Design of Photoactivatable Metallodrugs: Excited State Metallomics
 
Dr. Huayun Shi, Dr. Rafael C. Marchi, Prof. Peter J. Sadler
Department of Chemistry, University of Warwick, Coventry, CV4 7AL UK

 
First published: 13 January 2025

"...
Fasten your seat belt! Choose lightning-speed, photoactivated journeys for complexes by selecting the metal, its oxidation state, ligands and geometry. Track complexes through excited singlet (S) states, intersystem crossing (ISC) to triplet (T) states, energy/charge-transfer, luminescence, ligand substitutions and redox reactions. Pathways to novel drugs with new mechanisms of action. Unravelling excited metallomics on the way is challenging...."

"...Besides red-shifting the absorption band, another strategy to increase the effectiveness of metal-based photocatalysts is the formation of low-lying 3IL* and/or 3ILCT* states. Generally, low-lying excited states are favorable due to spin-orbit coupling between a ligand and a heavy atom, and their long lifetimes lengthen the time of interaction with substrates to form radicals.27 The remarkable photocytotoxicity of TLD1433 is based on this strategy, which facilitates the formation of ROS via Type I and II mechanisms.6 The Os(II) complex bearing four thiophenes rings derived from TLD1433, Os-1 (Figure4), exhibits a long-lived, low-lying 3ILCT state (τo=3–4μs) for the photoinduced production of O2⋅− and 1O2. Its phototoxicity indices (PI) are > 106 and > 70 under normoxia and hypoxia, respectively, despite the activation wavelengths (white visible light, 523nm and 633nm).28 The elevated phototoxicity under hypoxia can be attributed to a change in the character of the low-lying triplet excited state from 3MLCT* to 3ILCT* with increase in the number of thiophene rings..."

"...OPE (One-photon Excitation) is also frequently applied to complexes designed to combat antimicrobial resistance (AMR), a global issue. Photoactivatable metallodrugs for antimicrobial PDT (aPDT) can introduce damage to multiple bacterial targets by ROS generation.75 The Ru(II) drug TLD1433 for example shows activity against Staphylococcus aureus and resistant Staphylococcus aureus under green light through ROS generated by Type I and Type II mechanisms.76..."

"...The excited state dynamics of TLD1433 (Figure1) in MCF7 breast cancer cells using a modified transient absorption (TA) system in a vertical position that orients the laser pulses perpendicular to the plane of the optical table, has been studied.132 TLD1433 (40μM) in fixed MCF7 cells showed bi-exponential kinetics related with vibrational conversion from 3MLCT to 3ILCT (τ = 1.5ps) and vibration relaxation within 3ILCT (13ps). In cellulo measurements showed no decay of the long-lived 3ILCT in a 1.9ns window, while a decay (35 %) was observed in aqueous solution. The same kinetic profile was observed for highly concentrated TLD1433 in water (500μM) or when TLD1433 interacts with calf thymus DNA (ct-DNA) in solution. Moreover, TA microscopy showed the heterogeneity in excited-state dynamics across different cellular regions where the photosensitizer was densely concentrated, reflecting local environmental influences (Figure11b). This is a good example of how the cellular medium may alter the lifetime of the excited states, making them different from those tracked in solution. This work opens the possibility to explore in depth excited-state dynamics of photosensitizers in their relevant biological environment...."
Comment by Alamir1111 on Jan 14, 2025 2:22pm
1,119 Followers · Posts · Replies · Media. Theralase Technologies's posts ... Theralase What I see is independent researcher paste and copy original research to make them feel important .They not part of tlt team  don't contribute physically  nor financially they ussesles  leaches sucking public funds to stay relevant..They're research is worth as ...more  
Comment by rollthedice10 on Jan 14, 2025 3:39pm
I wouldn't doubt that. But if it brings eyeballs to Theralase I'm fine with it.
Comment by gonefishing2022 on Jan 14, 2025 7:03pm
If More and More people are watching. WHY ARE WE BELOW 30 CENTS
Comment by chry200030 on Jan 14, 2025 7:18pm
Because they are Watching. Not Buying.
Comment by rollthedice10 on Jan 15, 2025 9:37am
There are a lot of people looking for sure. I think they know this might just be the 100 bagger they dream of, but are being careful. The data so far is incredibly good but I think people want to see some sort of catalyst before they actually dive in. Most of us have lost money on picking stocks and are not in a hurry to keep losing. I did a lot of DD and watched TLT for a while before wading in ...more  
Comment by Maxcitrac on Jan 15, 2025 9:02am
Many thanks Eoganacht,. This is the second time that you come up with such a big find. These two great articles are like a gold mine of informations that will certainly make the job of Dr LBiati much easier when negotiating a big pharma deal. I am not even being pretentious by saying that these two articles are worth billion$ for Theralase credibility, because the scientist that wrote the ...more